Key terms

About EOLS

Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau. The company was founded by Scott Cannizzaro in November 2012 and is headquartered in Newport Beach, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest EOLS news

Apr 03 4:43pm ET Evolus Inc Announces Strategic Board Renewal Plans by TipRanks Mar 21 7:34am ET 5 Stocks Hedge Funds Love and have Analysts Support by TipRanks Mar 21 1:59am ET Evolus (NASDAQ:EOLS): An Attractive Aesthetics Stock for Growth Investors by TipRanks Mar 14 5:00am ET Analysts Offer Insights on Healthcare Companies: Sangamo Biosciences (SGMO) and Evolus (EOLS) by TipRanks Mar 11 7:25am ET Evolus 3.55M share Spot Secondary priced at $14.07 by TipRanks Mar 11 2:35am ET Evolus (EOLS) Receives a Buy from Barclays by TipRanks Mar 11 2:32am ET 3 Best Stocks to Buy Now, 3/11/2024, According to Top Analysts by TipRanks Mar 11 12:45am ET Evolus Poised for Growth: Buy Rating Affirmed with $25 Price Target Amid Profitability Forecast and Competitive Market Positioning by TipRanks Mar 08 8:25am ET Evolus price target raised to $25 from $23 at Stifel by TipRanks Mar 08 6:55am ET Evolus Poised for Growth: Surpassing Q4 Expectations and Accelerating Profitability by TipRanks Mar 08 6:41am ET Evolus price target raised to $23 from $20 at Mizuho by TipRanks Mar 08 6:27am ET Evolus: A Promising Trajectory Toward Profitability and Market Expansion by TipRanks Mar 07 4:30pm ET Evolus sees FY24 revenue $255M-$265M, consensus $261.17M by TipRanks Mar 07 4:29pm ET Evolus reports Q4 EPS (21c), consensus (7c) by TipRanks Mar 01 12:40pm ET Analysts Offer Insights on Healthcare Companies: Evolus (EOLS) and Akero Therapeutics (AKRO) by TipRanks Feb 05 4:20am ET Analysts Offer Insights on Healthcare Companies: Cigna (CI), Evolus (EOLS) and Hologic (HOLX) by TipRanks Jan 22 3:40pm ET Analysts Offer Insights on Healthcare Companies: Evolus (EOLS), Bristol-Myers Squibb (BMY) and Immunocore Holdings (IMCR) by TipRanks Jan 22 3:30pm ET Analysts’ Top Healthcare Picks: Instil Bio (TIL), Evolus (EOLS) by TipRanks Jan 22 3:20pm ET Analysts’ Top Healthcare Picks: Eli Lilly & Co (LLY), Exelixis (EXEL) by TipRanks Jan 22 3:01pm ET Analysts Offer Insights on Healthcare Companies: Lexaria Bioscience (LEXX), Evolus (EOLS) and Inspire Medical Systems (INSP) by TipRanks Jan 17 2:39am ET Evolus Stock (NASDAQ:EOLS) Spikes; Analysts See Significant Upside by TipRanks Jan 16 5:33pm ET Evolus sees FY24 revenue $255M-$265M, consensus $253.27M by TipRanks Jan 16 5:31pm ET Evolus sees Q4 revenue $61M, consensus $56.97M by TipRanks
Aug 08 5:15am ET Stonegate Capital Partners Announces Publishing of a Thematic Report - Undervalued Growth Pharma Companies Amidst Healthcare Sector Decline by NewsFile

EOLS Financials

1-year income & revenue

Key terms

EOLS Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

EOLS Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days
Students at Highlands High School, work on a practice test at the ACT Boot Camp in Newport, Ky.
Patrick Reddy/The Enquirer/AP/File
Private equity finds its next bet: college admissions
In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming
Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images
Samuel Corum/Bloomberg/Getty Images
Geopolitical strife is roiling Wall Street. Here’s what investors are watching